市場調查報告書
商品編碼
1434577
3D 細胞培養市場:按產品、應用和最終用戶分類 - 2024-2030 年全球預測3D Cell Culture Market by Product (3D Bio Printing, Magnetic Levitation, Microfluidics-based 3D Cell Culture), Application (Cancer, Drug Discovery, Stem Cell Research), End-User - Global Forecast 2024-2030 |
※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。
預計2023年3D細胞培養市場規模為16.2億美元,預計2024年將達17.3億美元,2030年將達26.7億美元,複合年成長率為7.34%。
3D 細胞培養的全球市場
主要市場統計 | |
---|---|
基準年[2023] | 16.2億美元 |
預測年份 [2024] | 17.3億美元 |
預測年份 [2030] | 26.7億美元 |
複合年成長率(%) | 7.34% |
3D細胞培養是指在允許生物細胞在3D上擴展的環境中培養生物細胞。此方法不同於傳統的2D方法,在傳統的2D方法中,細胞在培養皿等平坦表面上培養。在 3D 細胞培養中,細胞比 2D 方案更接近模仿人體細胞的行為,因此可以更準確地解釋體內條件。 3D 細胞培養正在幫助生物醫學研究的重要領域進行研究,包括組織再生、癌症生物學和藥物發現。近年來,器官移植的需求急劇增加,增加了對可以創建用於移植的仿生組織模型的3D培養的需求。然而,3D 細胞培養的開發需要複雜的基礎設施,並且可擴充性有限,阻礙了其採用。微加工和生物列印技術的進步有可能將 3D 細胞培養的應用擴展到實驗室建模的更複雜的器官系統。未來幾年,預計與 3D 細胞培養相關的研究活動將會增加,其在治療領域的應用也將增加。
區域洞察
在美洲,技術進步和大量研發投資正在擴大 3D 細胞培養在製藥和生物技術產業的使用。許多當地企業正在致力於製造 3D 細胞培養系統。該地區全面的法律規範和對細胞研究的重視進一步推動了市場的發展。由於醫療保健支出不斷增加、人口老化以及各種慢性疾病的流行,亞太地區成為 3D 細胞培養的新興市場。中國、日本和韓國的生物技術領域正在顯著成長,進一步促進了這些文化的應用和生產。歐洲也是一個重要的參與者,德國、英國和法國在細胞研究方面投入大量資金。 3D 細胞培養廣泛應用於癌症研究、藥物開發和再生醫學。該地區的公司受到歐洲藥品管理局 (EMA) 等機構全面監管的支持。與其他地區相比,中東和非洲地區雖然不是很發達,但正在穩步繁榮。整體醫療保健意識的提高、政府對醫療基礎設施的支出以及全球製藥公司的快速成長正在推動該地區的成長。
FPNV定位矩陣
FPNV定位矩陣對於評估3D細胞培養市場至關重要。我們檢視與業務策略和產品滿意度相關的關鍵指標,以對供應商進行全面評估。這種深入的分析使用戶能夠根據自己的要求做出明智的決策。根據評估,供應商被分為四個成功程度不同的像限:前沿(F)、探路者(P)、利基(N)和重要(V)。
市場佔有率分析
市場佔有率分析是一種綜合工具,可對 3D 細胞培養市場中供應商的現狀進行深入而詳細的研究。全面比較和分析供應商在整體收益、基本客群和其他關鍵指標方面的貢獻,以便更好地了解公司的績效及其在爭奪市場佔有率時面臨的挑戰。此外,該分析還提供了對該行業競爭特徵的寶貴見解,包括在研究基準年觀察到的累積、分散主導地位和合併特徵等因素。這種詳細程度的提高使供應商能夠做出更明智的決策並制定有效的策略,從而在市場上獲得競爭優勢。
1-市場滲透率:提供有關主要企業所服務的市場的全面資訊。
2-市場開拓:我們深入研究利潤豐厚的新興市場,並分析它們在成熟細分市場中的滲透率。
3- 市場多元化:提供有關新產品發布、開拓地區、最新發展和投資的詳細資訊。
4-競爭力評估與資訊:對主要企業的市場佔有率、策略、產品、認證、監管狀況、專利狀況、製造能力等進行全面評估。
5- 產品開發與創新:提供對未來技術、研發活動和突破性產品開發的見解。
1-3D細胞培養市場的市場規模與預測是多少?
2-在 3D 細胞培養市場的預測期內,有哪些產品、細分市場、應用和領域需要考慮投資?
3-3D細胞培養市場的技術趨勢和法律規範是什麼?
4-3D細胞培養市場主要廠商的市場佔有率是多少?
5-進入3D細胞培養市場的合適型態和策略手段是什麼?
[188 Pages Report] The 3D Cell Culture Market size was estimated at USD 1.62 billion in 2023 and expected to reach USD 1.73 billion in 2024, at a CAGR 7.34% to reach USD 2.67 billion by 2030.
Global 3D Cell Culture Market
KEY MARKET STATISTICS | |
---|---|
Base Year [2023] | USD 1.62 billion |
Estimated Year [2024] | USD 1.73 billion |
Forecast Year [2030] | USD 2.67 billion |
CAGR (%) | 7.34% |
3D cell culture refers to the practice of growing biological cells in an environment where they can extend in all three dimensions. This method differs from traditional 2D methods that grow cells on flat surfaces, such as petri dishes. In a 3D cell culture, the cells mimic the behavior of cells within the human body much closer compared to 2D protocols, allowing for a more accurate interpretation of in vivo conditions. 3D cell cultures are instrumental in studying critical areas in biomedical research such as tissue regeneration, cancer biology, and drug discovery. The demand for organ transplantations has increased dramatically in recent years, pushing the need for 3D cultures that can create biomimetic tissue models for transplantations. However, complex infrastructure requirements for 3D cell culture development and their limited scalability impede their adoption. With the advancement in microfabrication and bio-printing technologies, the application of 3D cell culture can extend into more complex organ systems to be modeled in the laboratory. In the coming years, we are expected to observe a rise in research activities on 3D cell culture and their increasing applications in therapeutic areas.
Regional Insights
In the American continent, the use of 3D cell culture in the pharma-biotech industry is prevalent due to technological advancement and hefty R&D investments. Many local corporations are working on the production of 3D cell culture systems. The region's comprehensive regulatory frameworks and a strong emphasis on cell research propel the market further. Asia-Pacific is an emerging market for 3D cell culture due to increasing healthcare expenditure, a rise in the aging population, and the prevalence of diverse chronic diseases. China, Japan, and South Korea are witnessing significant growth in the biotechnology sector, which further fuels the application and production of these cultures. Europe is also a significant player, with Germany, UK, and France heavily investing in cell research. 3D cell cultures are extensively used for oncological research, drug development, and regenerative medicines. Companies in the region are supported by comprehensive regulations from agencies, including the European Medicines Agency (EMA). In comparison to other regions, the MEA has a less developed but steadily prospering 3D cell culture scene. Increasing general healthcare awareness, government expenditure on healthcare infrastructure, and the burgeoning presence of global pharmaceutical companies mark the growth in this region.
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the 3D Cell Culture Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the 3D Cell Culture Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the 3D Cell Culture Market, highlighting leading vendors and their innovative profiles. These include 3D Biotek, LLC, Altis Biosystems, Inc., Avantor, Inc., Becton, Dickinson and Company, BellBrook Labs, Cellink by Bico Group, CN Bio Innovations Limited, Copner Biotech, Corning Inc., Curesponse Ltd., Electrospinning Company Ltd., Emulate, Inc., Greiner Bio-One International GmbH, Hamilton Company, InSphero AG, JSR Corporation, Known Medicine, Lonza Group AG, Merck KGaA, MIMETAS, Ovizio Imaging Systems SA/NV, PromoCell GmbH, Reprocell Inc., SARSTEDT AG & Co. KG, Spiderwort Inc., Synthecon Inc., Tecan Trading AG, Thermo Fisher Scientific, Inc, TissUse GmbH, and TreeFrog Therapeutics SAS.
Market Segmentation & Coverage
1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
1. What is the market size and forecast of the 3D Cell Culture Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the 3D Cell Culture Market?
3. What are the technology trends and regulatory frameworks in the 3D Cell Culture Market?
4. What is the market share of the leading vendors in the 3D Cell Culture Market?
5. Which modes and strategic moves are suitable for entering the 3D Cell Culture Market?